3CLpro inhibitors as a potential therapeutic option for COVID-19: Available evidence and ongoing clinical trials
Mekonnen Sisay
Topics & Concepts
Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Clinical trialMedicineIntensive care medicineCoronavirus InfectionsVirologyInternal medicineOutbreakDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesComputational Drug Discovery Methods